Definitive Healthcare (NASDAQ:DH) Downgraded by Wall Street Zen to Hold

Definitive Healthcare (NASDAQ:DH - Get Free Report) was downgraded by equities researchers at Wall Street Zen from a "buy" rating to a "hold" rating in a research note issued to investors on Saturday.

Several other brokerages have also recently issued reports on DH. BTIG Research cut Definitive Healthcare from a "buy" rating to a "neutral" rating in a research report on Friday, May 9th. The Goldman Sachs Group boosted their target price on Definitive Healthcare from $3.00 to $3.40 and gave the stock a "neutral" rating in a research report on Monday, May 12th. Finally, Barclays lowered their price target on Definitive Healthcare from $4.00 to $3.00 and set an "underweight" rating on the stock in a report on Monday, March 3rd. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, Definitive Healthcare currently has a consensus rating of "Hold" and an average target price of $5.10.

Definitive Healthcare Stock Down 1.2%

NASDAQ DH traded down $0.04 during trading on Friday, reaching $3.27. 836,505 shares of the company's stock were exchanged, compared to its average volume of 815,169. The stock has a market cap of $486.06 million, a P/E ratio of -1.05, a price-to-earnings-growth ratio of 4.06 and a beta of 1.48. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. The company has a 50 day moving average price of $2.86 and a two-hundred day moving average price of $3.76. Definitive Healthcare has a 1 year low of $2.15 and a 1 year high of $6.27.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.05 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.02 by $0.03. The company had revenue of $59.19 million during the quarter, compared to the consensus estimate of $56.20 million. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. Definitive Healthcare's revenue for the quarter was down 6.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.08 EPS. On average, equities research analysts anticipate that Definitive Healthcare will post 0.16 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the business. Price T Rowe Associates Inc. MD raised its position in shares of Definitive Healthcare by 20.5% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 20,572 shares of the company's stock worth $85,000 after buying an additional 3,496 shares during the period. Principal Financial Group Inc. raised its position in shares of Definitive Healthcare by 9.7% in the 4th quarter. Principal Financial Group Inc. now owns 43,960 shares of the company's stock worth $181,000 after buying an additional 3,874 shares during the period. Rhumbline Advisers increased its holdings in Definitive Healthcare by 5.2% in the 4th quarter. Rhumbline Advisers now owns 81,316 shares of the company's stock valued at $334,000 after purchasing an additional 4,034 shares in the last quarter. Canada Pension Plan Investment Board increased its holdings in Definitive Healthcare by 18.1% in the 4th quarter. Canada Pension Plan Investment Board now owns 29,300 shares of the company's stock valued at $120,000 after purchasing an additional 4,500 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Definitive Healthcare by 6.2% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 81,358 shares of the company's stock valued at $334,000 after purchasing an additional 4,748 shares in the last quarter. Hedge funds and other institutional investors own 98.67% of the company's stock.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.